17 Sep 2021 Uncategorised Coronavirus company news summary – Health Canada grants full approval to Moderna and Pfizer jabs – Lilly’s antibody combo to be used for Covid-19 post-exposure prophylaxis in US 17 Sep 2021
16 Sep 2021 Uncategorised Coronavirus company news summary – Lilly signs new antibody supply deal with US – Moderna notes waning vaccine immunity as it pushes for booster approval 16 Sep 2021
15 Sep 2021 Uncategorised Coronavirus company news summary – Regeneron to supply more antibody cocktail doses to US – CureVac ends European vaccine production contracts as demand drops 15 Sep 2021
14 Sep 2021 Uncategorised Coronavirus company news summary – UK scraps vaccine supply deal with Valneva – No evidence for universal Covid-19 booster shots, FDA and WHO scientists argue 14 Sep 2021
13 Sep 2021 Uncategorised Coronavirus company news summary – FDA lays out approach to Covid-19 vaccine safety in children – AzurRX activates Indian sites in Phase II trial of niclosamide 13 Sep 2021
09 Sep 2021 Uncategorised Coronavirus company news summary – Exscientia partners with Gates Foundation on infectious disease research – Novavax starts trial of combined Covid-19/influenza vaccine 09 Sep 2021
07 Sep 2021 Uncategorised Coronavirus company news summary – Japan to buy 150 million doses of Takeda-made Novavax vaccine – EMA reviews data on Pfizer-BioNTech booster shot 07 Sep 2021
06 Sep 2021 Uncategorised Coronavirus company news summary – Moderna submits Covid-19 booster vaccine data to European Medicines Agency – UK’s JCVI advises against universal vaccination for children aged 12-15 years 06 Sep 2021
03 Sep 2021 Uncategorised Coronavirus company news summary – AZ settles EU vaccine delivery lawsuit – US unveils $3bn vaccine supply chain investment plan 03 Sep 2021
